Evaluation in humans of ELF-EMF exposure on chromogranin A, a marker of neuroendocrine tumors and stress

References

• Ahlbom A, Day N, Feychting M, Roman E, Skinner J, Dockerty LM, McBride M, Michaelis J, Olsen JH, Tynes T, et al. 2000. A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer. 83:692–698.
   PubMed Web of Science ®Google Scholar
• Arnold R, Wilke A, Rinke A, Mayer C, Kann PH, Klose KJ, Scherag A, Hahmann M, Müller HH, Barth P. 2008. Plasma Chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors. Clin Gastroenterol Hepatol. 6:820–827.
   PubMed Web of Science ®Google Scholar
• Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Tomassetti P. 2007. Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol. 25:1967–1973.
   PubMed Web of Science ®Google Scholar
• Cimitan M, Buonadonna A, Cannizzaro R, Borsatti E, Ruffo R, De Apollonia L. 2003. Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: Clinical role. Ann Oncol. 14:1135–1141.
   PubMed Web of Science ®Google Scholar
• Corti A, Marcucci F, Bachetti T. 2018. Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers. Pflügers Archiv - Eur J Physiol. 470:199–210.
   PubMed Web of Science ®Google Scholar
• Den R, Toda M, Nagasawa S, Kitamura K, Morimoto K. 2007. Circadian rhythm of human salivary chromogranin A. Biomed Res. 28:57–60.
   PubMed Web of Science ®Google Scholar
• Di Giacinto P, Rota F, Rizza L, Campana D, Isidori A, Lania A, Lenzi A, Zuppi P, Baldelli R. 2018. Chromogranin A: from laboratory to clinical aspects of patients with neuroendocrineTumors. Int J Endocrinol. 8126087. eCollection 2018. doi:10.1155/2018/8126087.
   PubMed Web of Science ®Google Scholar
• Giampaolo B, Angelica M, Antonio S. 2002. Chromogranin “A” in normal subjects, essential hypertensives and adrenalectomized patients. Clin Endocrinol (Oxf). 57:41–50.
   PubMed Web of Science ®Google Scholar
• Grundy A, Harris SA, Demers PA, Johnson KC, Agnew DA; Canadian Cancer Registries Epidemiology Research Group. 2016. Occupational exposure to magnetic fields and breast cancer among Canadian men. Cancer Med. 5:586–596.
   PubMed Web of Science ®Google Scholar
• Helman LJ, Ahn TG, Levine MA, Allison A, Cohen PS, Cooper MJ, Cohn DV, Israel MA. 1988. Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. J Biol Chem. 263:11559–11563.
   PubMed Web of Science ®Google Scholar
• Hong R-H, Yang Y-J, Kim S-Y, Lee WY, Hong YP. 2009. Determination of appropriate sampling time for job stress assessment: The salivary chromogranin A and cortisol in adult females. J Prev Med Public Health. 42:231.
   PubMedGoogle Scholar
• Huang Y, Liu Z, Liu W, Yin C, Ci L, Zhao R, Yang X. 2017. Salivary haptoglobin and chromogranin A as non-invasive markers during restraint stress in pigs. Res Vet Sci. 114:27–30.
   PubMed Web of Science ®Google Scholar
• Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, Oberg K. 1997. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol. 8:685–690.
   PubMed Web of Science ®Google Scholar
• Jauchem JR. 1997. Exposure to extremely-low-frequency electromagnetic fields and radiofrequency radiation: cardiovascular effects in humans. Int Arch Occup Environ Health. 70:9–21.
   PubMed Web of Science ®Google Scholar
• Jeong JH, Kim JS, Lee BC, Min YS, Kim DS, Ryu JS, Soh KS, Seo KM, Sohn UD. 2005. Influence of exposure to electromagnetic field on the cardiovascular system. Auton Autacoid Pharmacol. 5:17–23.
   Google Scholar
• Jun E, Kim SC, Song KB, Song KB, Hwang DW, Lee JH, Shin SH, Hong SM, Park KM, Lee YJ. 2017. Diagnostic value of chromogranin A in pancreatic neuroendocrine tumors depends on tumor size: A prospective observational study from a single institute. Surgery. 162:120–130.
   PubMed Web of Science ®Google Scholar
• Kanai K, Hino M, Hori Y, Itoh N, Higuchi S. 2008. Circadian variations in salivary chromogranin A concentrations during a 24-hour period in dogs. J Vet Sci. 9:421–423.
   PubMed Web of Science ®Google Scholar
• Kheifets L, Crespi CM, Hooper C, Cockburn M, Amoon AT, Vergara XP. 2017. Residential magnetic fields exposure and childhood leukemia: a population-based case–control study in California. Cancer Causes Control. 28:1117–1123.
   PubMed Web of Science ®Google Scholar
• Koenig A, Krug S, Mueller D, Barth PJ, Koenig U, Scharf M, Ellenrieder V, Michl P, Moll R, Homayunfar K, et al. 2017. Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms. PLoS One. 12:e0188876.
   PubMed Web of Science ®Google Scholar
• Konecki DS, Benedum UM, Gerdes HH, Huttner WB. 1987. The primary structure of human chromogranin A and pancreastatin. J Biol Chem. 262:17026–17030.
   PubMed Web of Science ®Google Scholar
• Korse CM, Taal BG, Vincent A, van Velthuysen ML, Baas P, Buning-Kager JC, Linders TC, Bonfrer JM. 2012. Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments. Eur J Cancer. 48:662–671.
   PubMed Web of Science ®Google Scholar
• Linet MS, Hatch EE, Kleinerman RA, Robison LL, Kaune WT, Friedman DR, Severson RK, Haines CM, Hartsock CT, Niwa S, et al. 1997. Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med. 337:1–8.
   PubMed Web of Science ®Google Scholar
• Lv Y, Han X, Zhang C, Fang Y, Pu N, Ji Y, Wang D, Lou W. 2018. Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs. Endocr Connections. 7:169–178.
   PubMed Web of Science ®Google Scholar
• McBride ML, Gallagher RP, Thériault G, Armstrong BG, Tamaro S, Spinelli JJ, Deadman JE, Fincham S, Robson D, Choi W. 1999. Power-frequency electric and magnetic fields and risk of childhood leukemia in Canada. Am J Epidemiol. 149:831–842.
   PubMed Web of Science ®Google Scholar
• Nomura S, Mizuno T, Nozawa A, Asano H, Ide H. 2010. Characteristics of salivary Chromogranin A as a short-term mental stress biomarker. Trans Jap Soc Med Biol Eng. 48:207–212.
   Google Scholar
• O’Connor DT, Frigon RP. 1984. Chromogranin A, the major catecholamine storage vesicle soluble protein. Multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay. J Biol Chem. 259:3237–3247.
   PubMed Web of Science ®Google Scholar
• Pedersen C, Poulsen AH, Rod NH, Frei P, Hansen J, Grell K, Raaschou-Nielsen O, Schuz J, Johansen C. 2017. Occupational exposure to extremely low-frequency magnetic fields and risk for central nervous system disease: an update of a Danish cohort study among utility workers. Int Arch Occup Environ Health. 90:619–628.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. 2010. Ethics and methods for biological rhythm research on animals andhuman beings. Chronobiol Int. 27:1911–1929.
   PubMed Web of Science ®Google Scholar
• Savitz DA, Wachtel H, Barnes FA, John EM, Tvrdik JG. 1988. Case-control study of childhood cancer and exposure to 60-Hz magnetic fields. Am J Epidemiol. 128:21–38.
   PubMed Web of Science ®Google Scholar
• Selmaoui B, Aymard N, Lambrozo J, Touitou Y. 2003. Evaluation of the nocturnal levels of urinary biogenic amines in men exposed overnight to magnetic field. Life Sci. 73:3073–3082.
   PubMed Web of Science ®Google Scholar
• Selmaoui B, Bogdan A, Auzeby A, Lambrozo J, Touitou Y. 1996a. Acute exposure to 50 Hz magnetic field does not affect hematologic or immunologic functions in healthy young men. Bioelectromagnetics. 17:364–372.
   PubMed Web of Science ®Google Scholar
• Selmaoui B, Lambrozo J, Sackett-Lundeen L, Haus E, Touitou Y. 2011. Acute exposure to 50-Hz magnetic fields increases interleukin-6 in young healthy men. J Clin Immunol. 31(6):1105–1111.
   PubMed Web of Science ®Google Scholar
• Selmaoui B, Lambrozo J, Touitou Y. 1997. Endocrine functions in young men exposed for one night to a 50-Hz magnetic field. A circadian study of pituitary, thyroid and adrenocortical hormones. Life Sci. 61:473–486.
   PubMed Web of Science ®Google Scholar
• Selmaoui B, Lambrozo J, Touitou Y. 1999. Assessment of nocturnal exposure to 50-Hz magnetic fields on the human circadian system. A comprehensive study of biochemical variables. Chronobiol Intern. 16:789–810.
   PubMed Web of Science ®Google Scholar
• Selmaoui B, Touitou Y. 1996b. Magnetic fields and pineal function in humans: evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxy-melatonin circadian rhythm. Life Sci. 58:1539–1549.
   PubMed Web of Science ®Google Scholar
• Takiyyudin MA, Neuman HP, Cervenka JH, Kennedy B, T Q D, Zizgler MG, Baron AD, O’Connor DT. 1991. Ultradian variations of chromogranin A in humans. Am J Physiol. 261:R939–R944.
   PubMed Web of Science ®Google Scholar
• Taupenot L, Harper KL, O’Connor DT. 2003. The chromogranin-secretogranin family. N Engl J Med. 348:1134–1149.
   PubMed Web of Science ®Google Scholar
• Tomassetti P, Migliori M, Simoni P, Casadei R, De Iasio R, Corinaldesi R, Gullo L. 2001. Diagnostic value of plasma chromogranin A in neuroendocrine tumours. Eur J Gastroenterol Hepatol. 13:55–58.
   PubMed Web of Science ®Google Scholar
• Touitou Y, Coste O, Dispersyn G, Pain L. 2010. Disruption of the circadian system by environmental factors: effects of hypoxia, magnetic fields and general anesthetics agents. Adv Drug Deliv Rev. 62:928–945.
   PubMed Web of Science ®Google Scholar
• Touitou Y, Djeridane Y, Lambrozo J, Camus F. 2012b. Long-term (up to 20 years) effects of 50-Hz magnetic field exposure on blood chemistry parameters in healthy men. Clin Biochem. 11:425–428.
   Web of Science ®Google Scholar
• Touitou Y, Djeridane Y, Lambrozo J, Camus F, Selmaoui B. 2013. Long-term (up to 20years) effects of 50-Hz magnetic field exposure on immune system and hematological parameters in healthy men. Clin Biochem. 46:59–63.
   PubMed Web of Science ®Google Scholar
• Touitou Y, Lambrozo J, Camus F, Charbuy H. 2003. Magnetic fields and the melatonin hypothesis: a study of workers chronically exposed to 50-Hz magnetic fields. Am J Physiol-Regul Integr Comp Physiol. 284:R1529–R1535.
   PubMed Web of Science ®Google Scholar
• Touitou Y, Selmaoui B. 2012a. The effects of extremely low-frequency magnetic fields on melatonin and cortisol, two marker rhythms of the circadian system. Dialogues Clin Neurosci. 14:381–399.
   PubMedGoogle Scholar
• Touitou Y, Smolensky M, Portaluppi F. 2006. Ethics, standards, and procedures of animal and human chronobiology research. Chronobiol Int. 23:1083–1096.
   PubMed Web of Science ®Google Scholar
• Valdiglesias V, Maseda A, Lorenzo-Lopez L, Pasaro E, Calenti JCM, Blanca Laffon B. 2017. Is salivary Chromogranin A a valid psychological stress biomarker during sensory stimulation in people with advanced dementia? J Alzheimers Dis. 55:1509–1517.
   PubMed Web of Science ®Google Scholar
• Vila J, Turner MC, Gracia-Lavedan E, Figuerola J, Bowman JD, Kincl L, Richardson L, Benke G, Hours M, Krewski D, et al. 2018. Occupational exposure to high-frequency electromagnetic fields and brain tumor risk in the INTEROCC study: an individualized assessment approach. Environ Int. 119:353–365.
   PubMed Web of Science ®Google Scholar
• Welin S, Stridsberg M, Cunningham J, Granberg D, Skogseid B, Oberg K, Eriksson B, Janson ET. 2009. Elevated plasma Chromogranin Ais the first indication of recurrence in radically operated midgut carcinoid tumors. Neuroendocrinology. 89:302–307.
   PubMed Web of Science ®Google Scholar
• Wertheimer N, Leeper E. 1979. Electrical wiring configurations and childhood cancer. Am J Epidemiol. 109:273–284.
   PubMed Web of Science ®Google Scholar
• Wertheimer N, Leeper E. 1982. Adult cancer related to electrical wires near the home. Int J Epidemiol. 11:345–355.
   PubMed Web of Science ®Google Scholar
• WHO-World Health Organization. 2007. Extremely low frequency fields (Environment health criteria 238). Geneva (Switzerland): World Health Organization.
   Google Scholar